Roxadustat and the Interpretation of Non-Inferiority
freecme000
Published on Nov 29, 2022
CLICK ON LINK BELOW
https://www.asn-online.org/media/podcast/JASN/2022_04_11_JASN2021050681.mp3
Dr. Josie Briggs, discusses a non-inferiority trial on Roxadustat in dialysis patients and explains the interpretation of the finding that roxadustat is non-inferior to epoetin alpha.
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Podcast
Please Sign In or Create Account to use this feature!
Rate podcast
Please Sign In or Create Account to use this feature!
Rate podcast
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
00:04Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy
139 views 1409 days ago -
Watch Later
00:04Venous Thrombotic Events in ANCA-Associated Vasculitis: Incidence and Risk Factors
105 views 1409 days ago -
Watch Later
00:04 -
Watch Later
00:04 -
Watch Later
00:04New Vancomycin Dosing Guidelines for Hemodialysis Patients: Rationale, Caveats, and Limitations
209 views 1408 days ago -
Watch Later
00:04 -
Watch Later
![Trajectories of Serum Sodium on In-Hospital and 1-Year Survival among Hospitalized Patients​]()
00:04Trajectories of Serum Sodium on In-Hospital and 1-Year Survival among Hospitalized Patients​
129 views 1395 days ago -
Watch Later
![Addressing CKD Progression and Hazards of Intradialytic Hypotension]()
00:04Addressing CKD Progression and Hazards of Intradialytic Hypotension
156 views 1114 days ago
